AXIS | Zendy

Wolf R. Schäbitz | Zendy; Rico Laage | Zendy; Gerhard Vogt | Zendy; Winfried Koch | Zendy; Rainer Kollmar | Zendy; Stefan Schwab | Zendy; Dietmar Schneider | Zendy; Gerhard F. Hamann | Zendy; Michael Rosenkranz | Zendy; Roland Veltkamp | Zendy; Jochen B. Fiebach | Zendy; Werner Hacke | Zendy; James C. Grotta | Zendy; Marc Fisher | Zendy; Armin Schneider | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

AXIS

Author(s) -

Wolf R. Schäbitz,

Rico Laage,

Gerhard Vogt,

Winfried Koch,

Rainer Kollmar,

Stefan Schwab,

Dietmar Schneider,

Gerhard F. Hamann,

Michael Rosenkranz,

Roland Veltkamp,

Jochen B. Fiebach,

Werner Hacke,

James C. Grotta,

Marc Fisher,

Armin Schneider

Publication year - 2010

Publication title -

stroke

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.397

H-Index - 319

eISSN - 1524-4628

pISSN - 0039-2499

DOI - 10.1161/strokeaha.110.579508

Subject(s) - medicine , tolerability , stroke (engine) , placebo , adverse effect , clinical trial , dose , anesthesia , pathology , mechanical engineering , alternative medicine , engineering

Granulocyte colony-stimulating factor (G-CSF) is a promising stroke drug candidate. The present phase IIa study assessed safety and tolerability over a broad dose range of G-CSF doses in acute ischemic stroke patients and explored outcome data.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research